Wall Street's Insights Into Key Metrics Ahead of FMC Technologies (FTI) Q1 Earnings

22.04.25 15:15 Uhr

Werte in diesem Artikel
Aktien

32,96 EUR 0,00 EUR 0,00%

42,41 EUR -0,42 EUR -0,98%

22,07 EUR -0,38 EUR -1,69%

Indizes

PKT PKT

1.832,7 PKT 7,7 PKT 0,42%

1.886,5 PKT 6,9 PKT 0,36%

21.293,5 PKT 87,7 PKT 0,41%

8.130,7 PKT 26,3 PKT 0,32%

1.698,4 PKT 23,8 PKT 1,42%

2.975,3 PKT 0,8 PKT 0,03%

2.143,9 PKT 0,6 PKT 0,03%

197,3 PKT 3,3 PKT 1,68%

520,4 PKT 2,7 PKT 0,51%

11.184,3 PKT 64,5 PKT 0,58%

21.488,0 PKT 277,0 PKT 1,31%

21.427,0 PKT 167,5 PKT 0,79%

8.231,7 PKT 31,5 PKT 0,38%

16.484,6 PKT 88,0 PKT 0,54%

1.854,4 PKT -8,4 PKT -0,45%

In its upcoming report, FMC Technologies (FTI) is predicted by Wall Street analysts to post quarterly earnings of $0.36 per share, reflecting an increase of 63.6% compared to the same period last year. Revenues are forecasted to be $2.27 billion, representing a year-over-year increase of 11.1%.Over the last 30 days, there has been an upward revision of 0.1% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.With that in mind, let's delve into the average projections of some FMC Technologies metrics that are commonly tracked and projected by analysts on Wall Street.The consensus estimate for 'Revenue- Subsea Technologies' stands at $1.96 billion. The estimate suggests a change of +13% year over year.Analysts expect 'Revenue- Surface Technologies' to come in at $296.38 million. The estimate indicates a year-over-year change of -3.5%.Analysts predict that the 'Revenue- Lease' will reach $59.31 million. The estimate suggests a change of -4.8% year over year.Based on the collective assessment of analysts, 'Revenue- Product' should arrive at $785.57 million. The estimate indicates a change of -3.5% from the prior-year quarter.The combined assessment of analysts suggests that 'Revenue- Service' will likely reach $1.41 billion. The estimate points to a change of +20.8% from the year-ago quarter.Analysts forecast 'Inbound Orders - Subsea Technologies' to reach $2.47 billion. Compared to the present estimate, the company reported $2.40 billion in the same quarter last year.The consensus among analysts is that 'Order Backlog - Subsea Technologies' will reach $14.06 billion. Compared to the current estimate, the company reported $12.46 billion in the same quarter of the previous year.According to the collective judgment of analysts, 'Order Backlog - Total' should come in at $14.98 billion. Compared to the present estimate, the company reported $13.49 billion in the same quarter last year.It is projected by analysts that the 'Inbound Orders - Total' will reach $2.78 billion. Compared to the current estimate, the company reported $2.77 billion in the same quarter of the previous year.The collective assessment of analysts points to an estimated 'Order Backlog - Surface Technologies' of $909.26 million. Compared to the present estimate, the company reported $1.04 billion in the same quarter last year.The average prediction of analysts places 'Inbound Orders - Surface Technologies' at $317.59 million. The estimate compares to the year-ago value of $370.60 million.Analysts' assessment points toward 'Adjusted EBITDA- Subsea' reaching $331.05 million. Compared to the current estimate, the company reported $242.40 million in the same quarter of the previous year.View all Key Company Metrics for FMC Technologies here>>>Shares of FMC Technologies have experienced a change of -17.3% in the past month compared to the -8.9% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), FTI is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report TechnipFMC plc (FTI): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: FMC und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf FMC

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf FMC

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Fresenius Medical Care (FMC) St.

Wer­bung

Analysen zu Fresenius Medical Care (FMC) St.

DatumRatingAnalyst
14:01Fresenius Medical Care (FMC) St HoldDeutsche Bank AG
09:06Fresenius Medical Care (FMC) St BuyJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
08:21Fresenius Medical Care (FMC) St Equal WeightBarclays Capital
17.04.2025Fresenius Medical Care (FMC) St UnderweightJP Morgan Chase & Co.
16.04.2025Fresenius Medical Care (FMC) St Market-PerformBernstein Research
DatumRatingAnalyst
09:06Fresenius Medical Care (FMC) St BuyJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
12.03.2025Fresenius Medical Care (FMC) St BuyGoldman Sachs Group Inc.
27.02.2025Fresenius Medical Care (FMC) St KaufenDZ BANK
25.02.2025Fresenius Medical Care (FMC) St BuyGoldman Sachs Group Inc.
30.01.2025Fresenius Medical Care (FMC) St BuyJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
DatumRatingAnalyst
14:01Fresenius Medical Care (FMC) St HoldDeutsche Bank AG
08:21Fresenius Medical Care (FMC) St Equal WeightBarclays Capital
16.04.2025Fresenius Medical Care (FMC) St Market-PerformBernstein Research
04.03.2025Fresenius Medical Care (FMC) St Market-PerformBernstein Research
27.02.2025Fresenius Medical Care (FMC) St HoldWarburg Research
DatumRatingAnalyst
17.04.2025Fresenius Medical Care (FMC) St UnderweightJP Morgan Chase & Co.
21.03.2025Fresenius Medical Care (FMC) St UnderperformJefferies & Company Inc.
04.03.2025Fresenius Medical Care (FMC) St UnderperformJefferies & Company Inc.
26.02.2025Fresenius Medical Care (FMC) St UnderweightJP Morgan Chase & Co.
25.02.2025Fresenius Medical Care (FMC) St UnderperformJefferies & Company Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Fresenius Medical Care (FMC) St. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen